On July 28, 2019, White Winston Select Asset Fund Series Fund MP-18, LLC announced that pursuant to MusclePharm Corporation’s bylaws, it has notified the Company of its intention to nominate, and in fact nominated, the following individuals to be elected to the Company’s board of directors at the Company’s annual meeting: Lee Hillman; Chad Collins; Alexandra Lebenthal; and (4) Scott Butera.